The Phase 1b open label clinical trial is designed to evaluate the safety and hemodynamic effect of single doses of TX45 in patients with Group 2 pulmonary hypertension. Part A is examining the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback